XPA and colorectal carcinoma: Subgroup analysis based on age and tumor location suggested consistently significant down‐regulation of XPA in CRC tissues than in their adjacent tissues in age > 60 (P = 0.026), age ≤ 60 (P = 0.008), colon cancer (P = 0.009), and rectal cancer (P = 0.015).